OraSure’s ORAcollect®·RNA Device Included in EUA Granted to Quadrant Biosciences Inc. for COVID-19 Test
24 sept. 2020 06h00 HE
|
OraSure Technologies, Inc.
BETHLEHEM, Pa., Sept. 24, 2020 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point-of-care diagnostic tests, specimen collection devices, and microbiome laboratory and...
OraSure’s ORAcollect®·RNA Device Included in EUA Granted to MiraDx Inc. for SARS-CoV-2 Test
03 sept. 2020 16h30 HE
|
OraSure Technologies, Inc.
BETHLEHEM, Pa., Sept. 03, 2020 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point-of-care diagnostic tests, specimen collection devices, and microbiome laboratory and...
OraSure Technologies to Present at Upcoming Investor Conferences
27 août 2020 16h30 HE
|
OraSure Technologies, Inc.
BETHLEHEM, Pa., Aug. 27, 2020 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point of care diagnostic tests and specimen collection devices, and microbiome laboratory and...
OraSure Technologies, Inc. Announces 2020 Second Quarter Financial Results and Update on COVID-19 Testing Programs
05 août 2020 16h01 HE
|
OraSure Technologies, Inc.
BETHLEHEM, Pa., Aug. 05, 2020 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point-of-care diagnostic tests, specimen collection devices, and microbiome laboratory and...
OraSure’s OMNIgene®·ORAL Device Included in EUA Granted to Clinical Reference Laboratory for Self-Collected SARS-CoV-2 Saliva Test
31 juil. 2020 12h15 HE
|
OraSure Technologies, Inc.
BETHLEHEM, Pa., July 31, 2020 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point-of-care diagnostic tests, specimen collection devices, and microbiome laboratory and...
OraSure Technologies to Hold Second Quarter 2020 Earnings Conference Call on August 5th, 2020
22 juil. 2020 06h00 HE
|
OraSure Technologies, Inc.
2020 Second Quarter Earnings Conference Call Wednesday, August 5, 2020, 5:00 p.m. ET BETHLEHEM, Pa., July 22, 2020 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR) has scheduled its...
OraSure’s DNA Genotek Subsidiary Unveils First In-Home Self-Collection Device for Metabolomics
17 juin 2020 07h00 HE
|
OraSure Technologies, Inc.
OTTAWA, June 17, 2020 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point-of-care diagnostic tests, specimen collection devices, and microbiome laboratory and analytical...
OraSure Technologies Receives BARDA Funding for Coronavirus Antibody ELISA Using Oral Fluid Samples
10 juin 2020 08h00 HE
|
OraSure Technologies, Inc.
BETHLEHEM, Pa., June 10, 2020 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point-of-care diagnostic tests, specimen collection devices and microbiome laboratory and...
OraSure’s Oragene®•Dx included in EUA allowing at-home saliva collection for use with Phosphorus SARS-CoV-2 test
08 juin 2020 08h00 HE
|
OraSure Technologies, Inc.
OTTAWA, June 08, 2020 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point-of-care diagnostic tests, specimen collection devices, and microbiome laboratory and analytical...
OraSure Technologies, Inc. Announces Exercise of Option to Purchase Additional Shares of Common Stock
03 juin 2020 20h50 HE
|
OraSure Technologies, Inc.
BETHLEHEM, Pa., June 03, 2020 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (Nasdaq: OSUR) (“OraSure” or the “Company”) today announced the full exercise by the underwriters of their option to...